EUVIMEDEUVIMED entdecken
Open Access

Gadolinium during human pregnancy following administration of gadolinium chelate before pregnancy

Rachel M Coyte, Thomas Darrah, John Olesik, Emily Barrett, Thomas G O'Connor, Jessica Brunner, Tanzy Love, Rogelio Perez-D'Gregorio, Henry Z Wang, Lauren M Aleksunes, Brian Buckley, Cathleen Doherty und 1 weitere

Birth Defects Research · 15.08.2023 · 115 (14) · 1264-1273

DOI: 10.1002/bdr2.2209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Birth Defects Research, online erschienen am 19.06.2023. Verfasst von Rachel M Coyte und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Earth Sciences, The Ohio State University, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Contrast Media, Gadolinium. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NIH HHS, NIEHS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gadolinium (Gd), a toxic rare earth element, has been shown to dissociate from chelating agents and bioaccumulate within tissues, raising concerns about the possibility of their remobilization during pregnancy with subsequent free Gd exposures to developing fetuses. Gd chelates are among the most commonly used magnetic resonance imaging (MRI) contrast agents. This investigation was undertaken after the detection of elevated Gd (800–1000× higher than the usual rare earth element levels) in preliminary unpublished studies from the placentae of subjects in the NIH ECHO/UPSIDE Rochester Cohort Study and unpublished studies from placentae analyzed in formalin‐fixed placental specimens from Surgical Pathology at the University of Rochester. Fifteen pregnancies with elevated Gd were studied (12 first pregnancies and 3 second pregnancies). Maternal bloods were collected from all three trimesters, maternal, and cord (fetal) bloods at delivery as well as placental tissue. Breastmilk was also collected from selected mothers. It was determined that Gd was present in maternal bloods from all three trimesters, and in cord bloods and breastmilk in both first and second pregnancies. These results emphasize the need to fully appreciate the implications of pre‐pregnancy exposure to Gd chelates and its potential effects on maternal and fetal health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Contrast MediaGadoliniumHumansFemalePregnancyPlacentaCohort StudiesChelating AgentsMothersGravidity

Stichwörter der Autor:innen

breastmilkgadoliniumhumanmaternal and cord bloodspharmacokineticsplacentapregnancy

Substanzen

Contrast MediaGadoliniumChelating Agents

Autor:innen und Institutionen

  • School of Earth Sciences, The Ohio State University, Columbus, Ohio, USA.
  • Global Water Institute, The Ohio State University, Columbus, Ohio, USA.
  • Department of Obstetrics and Gynecology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
  • Department of Biostatistics and Epidemiology, Rutgers School of Public Health; Environmental and Occupational Health Sciences Institute, Piscataway, New Jersey, USA.
  • Department of Psychiatry, University of Rochester, School of Medicine and Dentistry, Rochester, New York, USA.
  • Department of Neuroscience, University of Rochester, School of Medicine and Dentistry, Rochester, New York, USA.

ORCID-Profile: Richard K Miller

Förderung

  • NICHD NIH HHS
  • NIH HHS
  • NIEHS NIH HHS
  • National Institutes of Health

Zitieren

APA

Coyte, R. M., Darrah, T., Olesik, J., Barrett, E., O'Connor, T. G., Brunner, J., Love, T., Perez-D'Gregorio, R., Wang, H. Z., Aleksunes, L. M., Buckley, B., Doherty, C., & Miller, R. K. (2023). Gadolinium during human pregnancy following administration of gadolinium chelate before pregnancy. Birth Defects Research, 115(14), 1264-1273. https://doi.org/10.1002/bdr2.2209

Vancouver

Coyte RM, Darrah T, Olesik J, Barrett E, O'Connor TG, Brunner J, et al. Gadolinium during human pregnancy following administration of gadolinium chelate before pregnancy. Birth Defects Research. 2023;115(14):1264-1273. doi:10.1002/bdr2.2209

BibTeX
@article{Coyte2023,
  author = {Coyte, Rachel M and Darrah, Thomas and Olesik, John and Barrett, Emily and O'Connor, Thomas G and Brunner, Jessica and Love, Tanzy and Perez-D'Gregorio, Rogelio and Wang, Henry Z and Aleksunes, Lauren M and Buckley, Brian and Doherty, Cathleen and Miller, Richard K},
  title = {Gadolinium during human pregnancy following administration of gadolinium chelate before pregnancy},
  journal = {Birth Defects Research},
  year = {2023},
  volume = {115},
  number = {14},
  pages = {1264--1273},
  doi = {10.1002/bdr2.2209}
}
Kostenlos starten →